Partner Dan Shores will serve as a panelist on the session "From Algorithms to Approvals: Harnessing AI to Accelerate Advanced Therapeutics While Managing Regulatory and IP Risks" at American Conference Institute's (ACI) 4th Annual Forum on Advanced Therapeutics taking place March 25-26, 2026, in Boston, Massachusetts. Dan's session will take place on the second day of the conference, March 26.
Artificial intelligence and data science are reshaping the trajectory of advanced therapeutics, yet the integration of AI also raises novel challenges around regulatory acceptance, data integrity, and intellectual property protections. This session will explore how AI can be leveraged to enhance speed, precision, and scalability in advanced therapeutic development while navigating the emerging legal and policy questions tied to its use. Dan and the other panelists will tackle topics including:
- How companies can effectively harness AI and machine learning for target selection, biomarker discovery, and trial optimization in advanced therapies
- Manufacturing innovation: Using AI to predict variability, optimize supply chains, and scale production for cell, gene, and RNA-based treatments
- Regulatory considerations: How FDA and global authorities are approaching AI-enabled therapeutic development and data validation
- IP and ownership questions: Who owns AI-generated insights, and how do they fit into patentability and freedom-to-operate frameworks? What are companies including in their patent filings when AI was used in the drug-discovery process?
- Strategic integration: Best practices for aligning AI-driven insights with existing R&D and commercialization strategies in advanced therapeutics
ACI’s Forum on Advanced Therapeutics returns with a renewed focus on the dynamic forces shaping the future of RNA, cell and gene therapies, and regenerative medicine. Designed for professionals across legal, regulatory, scientific, and business functions, the event dives into the evolving landscape of policy, IP, funding, innovation, and commercialization.
To learn more about ACI's Annual Forum on Advanced Therapeutics, and to register, please visit the event website.
